7nr3: Difference between revisions
Jump to navigation
Jump to search
m Protected "7nr3" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 7nr3 is ON HOLD | The entry 7nr3 is ON HOLD until Paper Publication | ||
Authors: O'Reilly, M. | Authors: O'Reilly, M. |
Revision as of 12:30, 31 March 2021
Unreleased structure
The entry 7nr3 is ON HOLD until Paper Publication
Authors: O'Reilly, M.
Description: Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2